Current NDC auxiliary source row compounder:309

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 83556-0422
Product Ndc: 83556-0422
Product Ndc Digits: 835560422
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Ceftazidime 22.5mg/mL
Proprietary Name Suffix: [empty]
Nonproprietary Name: Ceftazidime 22.5mg/mL
Dosage Form Name: INJECTION, SOLUTION
Route Name: INTRAOCULAR
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Turbare Manufacturing
Establishment Name: Turbare Manufacturing
Establishment Fei: [empty]
Substance Name: CEFTAZIDIME ANHYDROUS
Active Ingredients Info: 22.5 mg/1 mL
History Active Ingredients Raw: CEFTAZIDIME ANHYDROUS
History Active Ingredients Info Raw: 22.5 mg/1 mL
History Dosage Raw: INJECTION, SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 83556-0422-2
Package Ndc: 83556-0422-2
Package Ndc Digits: 8355604222
Package Ndc11: 83556042202
Package Description: .8 mL in 1 VIAL, GLASS (83556-0422-2)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:309
Source Row Number: 309
Source Row Hash: 8e4786f56dac65c079e947feb7f18a17051ba88809cf714ade22dfee0a6d60a3
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAOCULAR",
    "PRODUCTNDC": "83556-0422",
    "DEASCHEDULE": "",
    "LABELERNAME": "Turbare Manufacturing",
    "SUBSTANCENAME": "CEFTAZIDIME ANHYDROUS",
    "DOSAGEFORMNAME": "INJECTION, SOLUTION",
    "NDCPACKAGECODE": "83556-0422-2",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Ceftazidime 22.5mg/mL",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Ceftazidime 22.5mg/mL",
    "PACKAGEDESCRIPTION": ".8 mL in 1 VIAL, GLASS (83556-0422-2) ",
    "ACTIVEINGREDIENTSINFO": "22.5 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:309
Source Row Number: 309
Status Scope: package
Lookup Ndc: 83556-0422-2
Lookup Ndc Digits: 8355604222
Product Ndc: 83556-0422
Product Ndc Digits: 835560422
Package Ndc: 83556-0422-2
Package Ndc Digits: 8355604222
Package Ndc11: 83556042202
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 8e4786f56dac65c079e947feb7f18a17051ba88809cf714ade22dfee0a6d60a3
Import Run Id: 20261018T022251Z
Loaded At: 2026-10-18 02:29:51